Crossref
Structure-based optimization of orally bioavailable EP300-selective degraders
European Journal of Cancer · 2026-11 · 248 · 117613
DOI: 10.1016/j.ejca.2026.117613 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Cancer, 2026-11. Verfasst von T. Kim und 12 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Kim, T., Jang, S., Kang, S., Lee, Y., Shin, J., Park, A., Park, S., Lee, M., Jung, S., Kim, Y., Byun, J., Chon, H., & Ahn, Y. (2026). Structure-based optimization of orally bioavailable EP300-selective degraders. European Journal of Cancer, 248, 117613. https://doi.org/10.1016/j.ejca.2026.117613
Vancouver
Kim T, Jang S, Kang S, Lee Y, Shin J, Park A, et al. Structure-based optimization of orally bioavailable EP300-selective degraders. European Journal of Cancer. 2026;248:117613. doi:10.1016/j.ejca.2026.117613
BibTeX
@article{Kim2026,
author = {Kim, T. and Jang, S.Y. and Kang, S. and Lee, Y. and Shin, J. and Park, A. and Park, S. and Lee, M. and Jung, S. and Kim, Y.Y. and Byun, J. and Chon, H. and Ahn, Y.G.},
title = {Structure-based optimization of orally bioavailable EP300-selective degraders},
journal = {European Journal of Cancer},
year = {2026},
volume = {248},
pages = {117613},
doi = {10.1016/j.ejca.2026.117613}
}
EUVIMED